Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Alamar Biosciences, Inc.NASDAQ: ALMR

Net Margin · Q2 FY2026 · quarter ended Jun 2026

Net margin at -44.9%

Net margin was -44.9% in Q2 FY2026.

What to watch

Whether net margin reaches the consensus estimate from 3 analysts of -82.3% for the fiscal year ending Dec 2026, down from -40.2% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
-44.9%+37.1 pp QoQ
Last fiscal yearDec 2025
-40.2%— YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year—-42.2 pp—
3 years—+26.9 pp—
5 years+48.3 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
-40.2%
Year-over-year change
—
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 net margin of -40.2% is the 4th highest of the 8 companies compared; the peer median is -80.3%.
ALMR Competitors Peer median
Net Margin for ALMR and competitors
Company Period LTM level YoY 3-year change
TECHBio-Techne CorporationLTM Sep 202614.0% +7.6 pp-10.1 pp
TXG10x Genomics, Inc.LTM Sep 2026-10.8% +1.0 pp+25.4 pp
TWSTTwist Bioscience CorporationLTM Sep 2026-28.3% -7.7 pp+55.1 pp
ALMRAlamar Biosciences, Inc.FY2025-40.2% ——
PACBPacific Biosciences of California, Inc.LTM Mar 2026-80.3% +351.4 pp-96.5 pp
LABStandard BioTools Inc.LTM Mar 2026-109.1% -10.3 pp+106.3 pp
SEERSeer, Inc.LTM Mar 2026-468.7% +97.4 pp+176.5 pp
QSIQuantum-Si incorporatedLTM Mar 2026-5605.9% -2680.5 pp—
NAUTNautilus Biotechnology, Inc.FY2025— ——
Peer median (excluding ALMR) -80.3%+1.0 pp+40.3 pp

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.